Correlation Between UPI Semiconductor and Handa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both UPI Semiconductor and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UPI Semiconductor and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between uPI Semiconductor Corp and Handa Pharmaceuticals, you can compare the effects of market volatilities on UPI Semiconductor and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UPI Semiconductor with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of UPI Semiconductor and Handa Pharmaceuticals.

Diversification Opportunities for UPI Semiconductor and Handa Pharmaceuticals

0.21

Correlation Coefficient

UPI Semiconductor  Handa Pharmaceuticals

Modest diversification

The 3 months correlation between UPI and Handa is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding uPI Semiconductor Corp and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and UPI Semiconductor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on uPI Semiconductor Corp are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of UPI Semiconductor i.e., UPI Semiconductor and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between UPI Semiconductor and Handa Pharmaceuticals

Assuming the 90 days trading horizon UPI Semiconductor is expected to generate 15.43 times less return on investment than Handa Pharmaceuticals. But when comparing it to its historical volatility, uPI Semiconductor Corp is 2.69 times less risky than Handa Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  5,110  in Handa Pharmaceuticals on October 11, 2024 and sell it today you would earn a total of  2,290  from holding Handa Pharmaceuticals or generate 44.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

uPI Semiconductor Corp  vs.  Handa Pharmaceuticals

uPI Semiconductor Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days uPI Semiconductor Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, UPI Semiconductor is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Handa Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with UPI Semiconductor and Handa Pharmaceuticals

The main advantage of trading using opposite UPI Semiconductor and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UPI Semiconductor position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.

The idea behind uPI Semiconductor Corp and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.